Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.80    -1.80 (-1.86%)
Bid:
94.90
Ask:
95.20
Spread: 0.30 (0.316%)
Market Cap: £349.18m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Launch of EUR 15 Million Share Buyback Programme

21 Feb 2024 07:00

RNS Number : 8374D
C&C Group Plc
21 February 2024
 

C&C Group plc

Launch of ?15 Million Share Buyback Programme

 

Dublin, London 21 February 2024: C&C Group plc ('C&C' or the 'Group'), owners of the Tennent's, Magners and Bulmers Ireland brands, and Matthew Clark and Bibendum Wine, announces that it will commence a share buyback programme on 1 March 2024 to repurchase ordinary shares of the Group (the "Shares") up to a maximum aggregate consideration of ?15 million (the "Programme").

 

The Programme forms part of the Group's plan to return up to ?150 million to shareholders over the next three fiscal years as announced in October 2023 through a combination of dividends and share buybacks and follows the reinstatement of dividend payments last year. The Programme is underpinned by the Board's confidence in the medium-term outlook for the business and its strong cash generation capabilities. The Board also believes that the Programme represents the most effective use of capital in the current environment.

 

Details of the Programme

The Group has entered into an agreement with J&E Davy ("Davy") to act as principal to conduct the Programme and to repurchase Shares on the Group's behalf for a maximum aggregate consideration of up to ?15 million and to make trading decisions under the Programme in accordance with certain pre-set parameters. Under the terms of the agreement, Davy will make purchases of the Shares under the Programme independently of, and uninfluenced by, the Group.

 

The Programme will commence on 1 March 2024, and end no later than 30 June 2024, subject to market conditions. The purpose of the Programme is to reduce the share capital of the Company in line with this announcement. Under the terms of the Programme, the Shares will be repurchased on the London Stock Exchange and will be cancelled. The Programme will be conducted in accordance with:

 

(i) the Group's general authority to repurchase shares (which authorises the repurchase of up to 40,270,889 Shares, being approximately 10% of the issued share capital of the Group), as approved by shareholders at the Group's AGM held on 13 July 2023 (the "Authority"); and

 

(ii) the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052 (including as each of them forms part of retained EU law in the United Kingdom ("UK") from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the applicable laws and regulations of the UK Financial Conduct Authority.

 

The execution of the Programme may be augmented by the purchase of Shares by way of block trades effected by Davy as agent of the Group. The maximum number of Shares which can be repurchased by the Group under the Programme will be reduced by the corresponding number of Shares repurchased pursuant to any such block trades. Any Shares repurchased through block trades will also count towards the maximum consideration payable by the Group.

 

Details of any Shares repurchased under the Share Buyback Programme will be notified to a Regulatory Information Service by the Group following repurchase. Purchases may continue under the Programme during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

 

There is no guarantee that the Programme will be implemented in full or that any Shares will be bought back by the Group.

 

 

ENDS

 

 

Contacts

 

C&C Group plc Riona Heffernan, Group Finance & Investor Relations Director

Email: riona.heffernan@candcgroup.com

 

Investors, Analysts & Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Aline Oliveira

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 83 833 1644

Email: CandCGroup@fticonsulting.com

 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland. 

C&C Group's portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent's, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUROARSRUUUUR
Date   Source Headline
9th Jun 20264:53 pmRNSHolding(s) in Company
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company
13th Nov 20251:45 pmRNSHolding(s) in Company
3rd Nov 20253:09 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.